TROSPIUM CHLORIDE

N/A

Manufactured by Padagis US LLC

4,882 FDA adverse event reports analyzed

Last updated: 2026-04-15

About TROSPIUM CHLORIDE

TROSPIUM CHLORIDE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Padagis US LLC. The most commonly reported adverse reactions for TROSPIUM CHLORIDE include FALL, FATIGUE, URINARY TRACT INFECTION, DRUG INEFFECTIVE, DYSPNOEA. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for TROSPIUM CHLORIDE.

Top Adverse Reactions

FALL164 reports
FATIGUE156 reports
URINARY TRACT INFECTION131 reports
DRUG INEFFECTIVE125 reports
DYSPNOEA108 reports
ASTHENIA105 reports
HEADACHE101 reports
NAUSEA97 reports
GAIT DISTURBANCE95 reports
DIZZINESS93 reports
DIARRHOEA89 reports
PAIN86 reports
ARTHRALGIA82 reports
OFF LABEL USE80 reports
VOMITING77 reports
CONSTIPATION74 reports
MALAISE69 reports
ANAEMIA68 reports
DECREASED APPETITE61 reports
DEATH60 reports
ACUTE KIDNEY INJURY59 reports
CONFUSIONAL STATE59 reports
PRURITUS59 reports
COUGH56 reports
COVID 1956 reports
MUSCULAR WEAKNESS55 reports
OEDEMA PERIPHERAL54 reports
TREMOR54 reports
URINARY RETENTION53 reports
GENERAL PHYSICAL HEALTH DETERIORATION52 reports
DRY MOUTH51 reports
HYPERTENSION51 reports
DEPRESSION50 reports
PYREXIA50 reports
MYOCARDIAL INFARCTION48 reports
HYPONATRAEMIA47 reports
PERIPHERAL SWELLING47 reports
WEIGHT DECREASED46 reports
DYSPEPSIA45 reports
INSOMNIA45 reports
CORONARY ARTERY DISEASE44 reports
PNEUMONIA44 reports
ABDOMINAL DISCOMFORT42 reports
PAIN IN EXTREMITY42 reports
DRUG INTERACTION41 reports
SOMNOLENCE41 reports
HYPOTENSION40 reports
CONDITION AGGRAVATED39 reports
HALLUCINATION39 reports
ANXIETY38 reports
BACK PAIN38 reports
MULTIPLE SCLEROSIS RELAPSE38 reports
URINARY INCONTINENCE38 reports
ALOPECIA36 reports
MUSCLE SPASMS36 reports
SINUSITIS36 reports
GASTROINTESTINAL HAEMORRHAGE35 reports
PRODUCT DOSE OMISSION ISSUE35 reports
DEHYDRATION34 reports
FAECALOMA34 reports
HYPOAESTHESIA34 reports
MEMORY IMPAIRMENT34 reports
RASH34 reports
VISION BLURRED34 reports
FEELING ABNORMAL33 reports
HAEMATURIA33 reports
MITRAL VALVE INCOMPETENCE33 reports
SYNCOPE33 reports
ATRIAL FIBRILLATION32 reports
AORTIC VALVE STENOSIS31 reports
ABDOMINAL PAIN30 reports
ABDOMINAL PAIN UPPER30 reports
BLOOD PRESSURE INCREASED30 reports
GROIN PAIN30 reports
HYPERKALAEMIA30 reports
BALANCE DISORDER29 reports
PULMONARY HYPERTENSION29 reports
ANURIA28 reports
ERUCTATION28 reports
HIATUS HERNIA28 reports
IMPAIRED HEALING28 reports
JOINT DISLOCATION28 reports
LOSS OF CONSCIOUSNESS28 reports
PALPITATIONS28 reports
CARDIOGENIC SHOCK27 reports
CARDIOVASCULAR DISORDER27 reports
DIVERTICULUM INTESTINAL27 reports
ESCHERICHIA INFECTION27 reports
INFLAMMATORY MARKER INCREASED27 reports
OSTEOPENIA27 reports
POSTOPERATIVE WOUND INFECTION27 reports
DRY SKIN26 reports
LEFT VENTRICULAR DYSFUNCTION26 reports
SEPSIS26 reports
WEIGHT INCREASED26 reports
WOUND DEHISCENCE26 reports
ARTERIAL HAEMORRHAGE25 reports
FEMORAL HERNIA INCARCERATED25 reports
HEPATIC CYST25 reports
HYPERSENSITIVITY25 reports

Report Outcomes

Out of 2,140 classified reports for TROSPIUM CHLORIDE:

Serious 69.8%Non-Serious 30.2%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female1,276 (65.4%)
Male672 (34.4%)
Unknown4 (0.2%)

Reports by Age

Age 8266 reports
Age 7351 reports
Age 7448 reports
Age 7145 reports
Age 7945 reports
Age 7542 reports
Age 7642 reports
Age 6241 reports
Age 7837 reports
Age 6433 reports
Age 6533 reports
Age 7733 reports
Age 7232 reports
Age 8032 reports
Age 6731 reports
Age 6831 reports
Age 6630 reports
Age 6930 reports
Age 8429 reports
Age 6127 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with TROSPIUM CHLORIDE?

This profile reflects 4,882 FDA FAERS reports that mention TROSPIUM CHLORIDE. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for TROSPIUM CHLORIDE?

Frequently reported terms in FAERS include FALL, FATIGUE, URINARY TRACT INFECTION, DRUG INEFFECTIVE, DYSPNOEA, ASTHENIA. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures TROSPIUM CHLORIDE?

Labeling and FAERS entries often list Padagis US LLC in connection with TROSPIUM CHLORIDE. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.